Logo for Clearside Biomedical Inc

Clearside Biomedical Investor Relations Material

Latest events

Logo for Clearside Biomedical Inc

Q3 2024

Clearside Biomedical
Logo for Clearside Biomedical

Q3 2024

12 Nov, 2024
Logo for Clearside Biomedical

Study Result

9 Oct, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Clearside Biomedical Inc

Access all reports
Clearside Biomedical, Inc. is a biopharmaceutical company specializing in the development of therapies for the treatment of eye diseases. The company focuses on treating conditions affecting the retina and choroid through its proprietary SCS Microinjector platform, which delivers drugs directly to the back of the eye. Clearside's approach aims to enhance the efficacy of treatments for serious vision-threatening diseases, including macular edema and uveitis. The company is headquartered in Alpharetta, United States, and its shares are listed on the NASDAQ.